Diet breakthrough: Monash University researchers find simpler alternative to intermittent fasting
Posted: 12 February 2024 Monash University scientists have identified a less stringent and more manageable alternative to traditional intermittent fasting, offering new possibilities for extending lifespan and promoting healthy ageing. This novel method, involving short-term isoleucine deprivation, has…
Ichor Clinical partners with CROs in Australia, Ireland and UK
Posted: 12 February 2024 Ichor Life Sciences has established operations in Australia, Ireland, and the UK by partnering with local contractors. The move saw US clinical research organization (CRO) Ichor establish collaborative service offerings with “concierge and boutique”…
One step closer to a blood test for diagnosing Alzheimer’s
Posted: 12 February 2024 A Melbourne study showing the efficacy of a simple blood test to detect the earlier stages of Alzheimer’s has brought us one step closer to a ‘game-changer’ for dementia diagnostics. Australian Dementia Network (ADNeT)…
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
Posted: 12 February 2024 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an independent Data Monitoring Committee (DMC) has completed its…
Five Victorian Cancer Agency grants awarded to Peter Mac Researchers
Posted: 12 February 2024 In alignment with World Cancer Day, Minister for Health Mary-Anne Thomas announced funding for 13 Victorian Cancer Agency fellowships with Peter Mac researchers receiving almost half of the fellowships. The fellowships covered low-survival cancers,…
$20 million to find new treatments for DIPG and other childhood brain cancers
Posted: 12 February 2024 The Albanese Government is funding a wide-ranging national research program that will give new hope and help to Australian children, adolescents and young adults with childhood brain cancers, including Diffuse Intrinsic Pontine Glioma (DIPG).…
AI-powered digital health products headline fresh funding from Medical Research Future Fund
Posted: 12 February 2024 An AI-powered system enabling improved treatment of macular degeneration, one of the biggest causes of preventable blindness, and an AI-supported wearable device seeking to prevent post-partum haemorrhage, a leading cause of maternal deaths, are…
Lab-grown tumours predict treatment outcomes in landmark study
Posted: 12 February 2024 Researchers have grown tumours in the lab to accurately predict what drugs will work for people with bowel cancer – before they begin treatment. The world-first study led by WEHI found drug testing on…
Better treatments sooner – Hudson’s new RNAte Platform unveiled
Posted: 12 February 2024 Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here…
The Adjutor Healthcare Group Expands Global Presence with the Establishment of Adjutor Healthcare Hong Kong
Posted: 12 February 2024 Today marks a significant milestone for the Adjutor Healthcare Group, as we proudly announce the establishment of Adjutor Healthcare Hong Kong, further solidifying our commitment to excellence supporting global healthcare, development, regulatory and commercialisation…
PRODUCTLIFE GROUP ACQUIRES COMMERCIAL EYES, EXPANDING ITS FOOTPRINT IN THE APAC REGION
Posted: 1 February 2024 ProductLife Group (PLG), the specialised global provider of regulatory, scientific, vigilance, quality and digital transformation consulting services for the life sciences industries, announces the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device…
Cumming Global Centre for Pandemic Therapeutics awards AU$17 million in grant funding
Posted: 1 February 2024 Developing antiviral therapeutics for respiratory infections using gene editing and mRNA technologies and creating a suite of precision microbiome-based biotherapeutics are just two groundbreaking projects being funded by the Cumming Global Centre for Pandemic…
